Dr. John Kane discussed the RAISE trial for people with first episode psychosis

Professor David Nutt

Edmond J Safra Professor of Neuropsychopharmacology in the Division of Brain Sciences Imperial College London, UK.

View all of our content on Schizophrenia
Published 21.01.2018
Permissions
Published 21.01.2018
Permissions

Related content

Dopamine in Parkinson’s Disease and Schizophrenia play_circle Video play_circle
Dopamine in Parkinson’s Disease and Schizophrenia

Professors Shen-Yang Lim and Christoph Correll explore dopamine’s role in Parkinson’s disease and schizophrenia, discussing treatment evolution, side effects, and parallels between the disorders. Access more resources at Neurotorium.org.

04.12.2024 Parkinson’s Disease
Schizophrenia and Substance Use Disorders Comorbidity play_circle Video play_circle
Schizophrenia and Substance Use Disorders Comorbidity

Professors Christoph Correll and Gabriele Fischer discuss the challenges of managing co-occurring schizophrenia and substance use disorders, offering insights into this complex comorbidity.

04.12.2024 Schizophrenia
description Article
The Use of Virtual Reality in the Treatment of Severe Mental Illnesses: The Example of Psychosis

The use of virtual reality in the treatment of severe mental illnesses

06.10.2024 Schizophrenia